Hepatitis C

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease
G Svegliati-Baroni, E Bugianesi, T Bouserhal, F Marini, F Ridolfi, F Tarsetti, F Ancarani, E Petrelli, E Peruzzi, M Lo Cascio, M Rizzetto, G Marchesini, A Benedetti

Gut Sep 2007, 56 (9) 1296-1301; DOI: 10.1136/gut.2006.107946
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
Maria Stepanova, Nila Rafiq, Zobair M Younossi

Gut Oct 2010, 59 (10) 1410-1415; DOI: 10.1136/gut.2010.213553
SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C
M Romero-Gómez, M A Montes-Cano, M A Otero-Fernández, B Torres, D Sánchez-Muñoz, F Aguilar, N Barroso, L Gómez-Izquierdo, V M Castellano-Megias, A Núñez-Roldán, J Aguilar-Reina, M F González-Escribano

Gut Mar 2004, 53 (3) 446-450; DOI: 10.1136/gut.2003.028274
New developments in the treatment of hepatitis C
S J Rossi, T L Wright

Gut May 2003, 52 (5) 756-757; DOI: 10.1136/gut.52.5.756
P42 Role of Acoustic Radiation Force Impulse (ARFI) elastography in the non-invasive assessment of liver fibrosis in chronic viral hepatitis: a simultaneous comparison with liver histology in a secondary care setting
K Kandiah, M J Sangwaiya, P Tadrous, P Shorvon, D Sherman

Gut Sep 2011, 60 (Suppl 2) A20; DOI: 10.1136/gutjnl-2011-300857a.42
Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
M Piazza, R Orlando, G Tosone, D Tiseo, M C Conte, F Minervini, G Santoro, F Scordino, D Vitale

Gut Jan 1993, 34 (2 Suppl) S128-S129; DOI: 10.1136/gut.34.2_Suppl.S128
Quantitative hepatitis C virus RNA and liver histology in chronic hepatitis C patients treated with interferon alfa.
G Yamada, M Takahashi, H Endo, T Doi, R Miyamoto, H Shimomura, K Yamamoto, T Tsuji

Gut Jan 1993, 34 (2 Suppl) S133-S134; DOI: 10.1136/gut.34.2_Suppl.S133
Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
C De Bac, F Grimaldi, C Clementi, F Duca, D Livoli, G Taliani

Gut Jan 1993, 34 (2 Suppl) S135; DOI: 10.1136/gut.34.2_Suppl.S135
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon α mono and combination therapy regimens
M Schmid, A Kreil, W Jessner, M Homoncik, C Datz, A Gangl, P Ferenci, M Peck-Radosavljevic

Gut Jul 2005, 54 (7) 1014-1020; DOI: 10.1136/gut.2004.057893
Outcomes of interferon α and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases
C-K Hui, A Monto, T Belaye, E Lau, T L Wright

Gut Nov 2003, 52 (11) 1644-1648; DOI: 10.1136/gut.52.11.1644

Main menu

Hepatitis C

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hepatitis C

Pages